User menu

Magnetic resonance (MR) imaging to assess the risk for disease progression in patients with stage I multiple myeloma (MMI) and monoclonal gammapathy of undetermined significance (MGUS).

Bibliographic reference Berg, BV. ; Michaux, Lucienne ; Lecouvet, Frédéric ; Ferrant, Augustin ; Malghem, Jacques ; et. al. Magnetic resonance (MR) imaging to assess the risk for disease progression in patients with stage I multiple myeloma (MMI) and monoclonal gammapathy of undetermined significance (MGUS)..In: Blood, Vol. 86, no. 10, p. 3364-3364 (1995)
Permanent URL http://hdl.handle.net/2078.1/62982